Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leanbio
Barcelona, Catalonia, Spainleanbiopro.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Leanbio has supported the development of over 100 biologic candidates for clients—including recombinant proteins and antibodies—some reaching late-stage clinical trials. It provides end-to-end CDMO services including process development and GMP manufacturing up to commercial scale. Its joint venture Syna Therapeutics licensed its first biosimilar to Accord Healthcare in 2023.
- Therapeutic areas
- OncologyImmunologyHematologyOtherInfectious Diseases
- Modalities
- Recombinant proteinMonoclonal antibodyAntibody-drug conjugateEnzyme replacement therapy (enzymes)mRNA-based drugs (mRNA)Plasmid DNA (pDNA)Fab fragments
- Industry
- Contract Manufacturing Organization
02
Partnerships
Reig Jofre (strategic investor/partner)Syna Therapeutics joint venture with Reig Jofre for biosimilar/innovative molecule co-development.Accord Healthcare (licensed first biosimilar from Syna Therapeutics JV in 2023)
Beyond the preview
Go deeper on Leanbio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leanbio.